Philippe Amouyal - Net Worth and Insider Trading
Philippe Amouyal Net Worth
The estimated net worth of Philippe Amouyal is at least $2 Million dollars as of 2024-12-28. Philippe Amouyal is the Director of Cava Group Inc and owns about 15,000 shares of Cava Group Inc (CAVA) stock worth over $2 Million. Philippe Amouyal is the Director of Lexicon Pharmaceuticals Inc and owns about 240,332 shares of Lexicon Pharmaceuticals Inc (LXRX) stock worth over $185,873. Philippe Amouyal is also the Director of WW International Inc and owns about 46,769 shares of WW International Inc (WW) stock worth over $59,864. Details can be seen in Philippe Amouyal's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Philippe Amouyal has not made any transactions after 2023-11-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Philippe Amouyal
Philippe Amouyal Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Philippe Amouyal owns 4 companies in total, including Lexicon Pharmaceuticals Inc (LXRX) , WW International Inc (WW) , and Blue Buffalo Pet Products Inc (BUFF) among others .
Click here to see the complete history of Philippe Amouyal’s form 4 insider trades.
Insider Ownership Summary of Philippe Amouyal
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LXRX | Lexicon Pharmaceuticals Inc | 2023-11-13 | director |
| WW | WW International Inc | 2018-08-31 | director |
| BUFF | Blue Buffalo Pet Products Inc | 2018-04-24 | director |
 | | 2023-11-17 | director |
Philippe Amouyal Latest Holdings Summary
Philippe Amouyal currently owns a total of 3 stocks. Among these stocks, Philippe Amouyal owns 15,000 shares of Cava Group Inc (CAVA) as of November 17, 2023, with a value of $2 Million and a weighting of 87.47%. Philippe Amouyal owns 240,332 shares of Lexicon Pharmaceuticals Inc (LXRX) as of November 13, 2023, with a value of $185,873 and a weighting of 9.48%. Philippe Amouyal also owns 46,769 shares of WW International Inc (WW) as of August 31, 2018, with a value of $59,864 and a weighting of 3.05%.
Latest Holdings of Philippe Amouyal
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CAVA | Cava Group Inc | 2023-11-17 | 15,000 | 114.37 | 1,715,550 |
| LXRX | Lexicon Pharmaceuticals Inc | 2023-11-13 | 240,332 | 0.77 | 185,873 |
| WW | WW International Inc | 2018-08-31 | 46,769 | 1.28 | 59,864 |
Holding Weightings of Philippe Amouyal
Philippe Amouyal Form 4 Trading Tracker
According to the SEC Form 4 filings, Philippe Amouyal has made a total of 1 transactions in Cava Group Inc (CAVA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cava Group Inc is the acquisition of 10,000 shares on November 17, 2023, which cost Philippe Amouyal around $331,800.
According to the SEC Form 4 filings, Philippe Amouyal has made a total of 1 transactions in Lexicon Pharmaceuticals Inc (LXRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Lexicon Pharmaceuticals Inc is the acquisition of 200,000 shares on November 13, 2023, which cost Philippe Amouyal around $202,000.
According to the SEC Form 4 filings, Philippe Amouyal has made a total of 0 transactions in WW International Inc (WW) over the past 5 years. The most-recent trade in WW International Inc is the sale of 7,500 shares on August 31, 2018, which brought Philippe Amouyal around $566,925.
Insider Trading History of Philippe Amouyal
- 1
Philippe Amouyal Trading Performance
GuruFocus tracks the stock performance after each of Philippe Amouyal's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Philippe Amouyal is 116.97%. GuruFocus also compares Philippe Amouyal's trading performance to market benchmark return within the same time period. The performance of stocks bought by Philippe Amouyal within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Philippe Amouyal's insider trading performs compared to the benchmark.
Performance of Philippe Amouyal
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 18.49 | | | | | |
| Relative Return to S&P 500(%) | 12.87 | | | | | |
Philippe Amouyal Ownership Network
Philippe Amouyal Owned Company Details
What does Lexicon Pharmaceuticals Inc do?
Who are the key executives at Lexicon Pharmaceuticals Inc?
Philippe Amouyal is the director of Lexicon Pharmaceuticals Inc. Other key executives at Lexicon Pharmaceuticals Inc include director & President and CEO Lonnel Coats , director & 10 percent owner Raymond Debbane , and SVP & Chief Commercial Officer Thomas Garner .
Lexicon Pharmaceuticals Inc (LXRX) Insider Trades Summary
Over the past 18 months, Philippe Amouyal made 1 insider transaction in Lexicon Pharmaceuticals Inc (LXRX) with a net purchase of 200,000. Other recent insider transactions involving Lexicon Pharmaceuticals Inc (LXRX) include a net purchase of 110,000 shares made by Lonnel Coats , a net purchase of 1,000,000 shares made by Raymond Debbane , and a net purchase of 10,000 shares made by Jeffrey L Wade .
In summary, during the past 3 months, insiders sold 0 shares of Lexicon Pharmaceuticals Inc (LXRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lexicon Pharmaceuticals Inc (LXRX) were sold and 1,326,000 shares were bought by its insiders, resulting in a net purchase of 1,326,000 shares.
Lexicon Pharmaceuticals Inc (LXRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lexicon Pharmaceuticals Inc Insider Transactions
Philippe Amouyal Mailing Address
Above is the net worth, insider trading, and ownership report for Philippe Amouyal. You might contact Philippe Amouyal via mailing address: C/o Cava Group, Inc., 14 Ridge Square Nw, Suite 500, Washington Dc 20016.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
